John Bell - Publications

University of Alberta, Edmonton, Alberta, Canada 

72 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Bo A, Chen K, Pickering E, Zhan H, Bell J, Du A, Zhang Y, Wang X, Zhu H, Shan Z, Gu Y. Atypical Defect Motions in Brittle Layered Sodium Titanate Nanowires. The Journal of Physical Chemistry Letters. PMID 30222361 DOI: 10.1021/acs.jpclett.8b02349  0.32
2017 Pelin A, Wang J, Bell J, Le Boeuf F. The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses. Oncolytic Virotherapy. 7: 25-35. PMID 29637059 DOI: 10.2147/OV.S137159  0.32
2017 Kim M, Nitschké M, Sennino B, Murer P, Schriver BJ, Bell AM, Subramanian A, McDonald CE, Wang J, Cha H, Bourgeois-Daigneault MC, Kirn DH, Bell JC, De Silva N, Breitbach CJ, et al. Amplification of oncolytic vaccinia virus widespread tumor cell killing by sunitinib through multiple mechanisms. Cancer Research. PMID 29259007 DOI: 10.1158/0008-5472.CAN-15-3308  0.32
2017 Guo ZS, Liu Z, Sathaiah M, Wang J, Ravindranathan R, Kim E, Huang S, Kenniston TW, Bell JC, Zeh HJ, Butterfield LH, Gambotto A, Bartlett DL. Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus. Molecular Therapy. Methods & Clinical Development. 7: 112-122. PMID 29085848 DOI: 10.1016/j.omtm.2017.09.007  0.32
2017 Jiao Y, Ma F, Zhang C, Bell J, Sanvito S, Du A. First-Principles Prediction of Spin-Polarized Multiple Dirac Rings in Manganese Fluoride. Physical Review Letters. 119: 016403. PMID 28731769 DOI: 10.1103/PhysRevLett.119.016403  0.32
2016 Wang J, Arulanandam R, Wassenaar R, Falls T, Petryk J, Paget J, Garson K, Cemeus C, Vanderhyden B, Wells G, Bell J, Le Boeuf F. Enhancing expression of functional human sodium iodide symporter and somatostatin receptor in recombinant oncolytic vaccinia virus for in vivo imaging of tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27635026 DOI: 10.2967/jnumed.116.180463  0.32
2016 Tang VA, Renner TM, Varette O, Le Boeuf F, Wang J, Diallo JS, Bell JC, Langlois MA. Single-particle characterization of oncolytic vaccinia virus by flow virometry. Vaccine. PMID 27614781 DOI: 10.1016/j.vaccine.2016.08.074  0.32
2016 Bourgeois-Daigneault MC, St-Germain LE, Roy DG, Pelin A, Aitken AS, Arulanandam R, Falls T, Garcia V, Diallo JS, Bell JC. Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment. Breast Cancer Research : Bcr. 18: 83. PMID 27503504 DOI: 10.1186/s13058-016-0744-y  0.72
2016 Keller BA, Bell JC. Oncolytic viruses-immunotherapeutics on the rise. Journal of Molecular Medicine (Berlin, Germany). PMID 27492706 DOI: 10.1007/s00109-016-1453-9  0.72
2016 Jiao Y, Ma F, Bell J, Bilic A, Du A. Two-Dimensional Boron Hydride Sheets: High Stability, Massless Dirac Fermions, and Excellent Mechanical Properties. Angewandte Chemie (International Ed. in English). PMID 27460282 DOI: 10.1002/anie.201604369  0.32
2016 Dornan MH, Krishnan R, Macklin AM, Selman M, El Sayes N, Son HH, Davis C, Chen A, Keillor K, Le PJ, Moi C, Ou P, Pardin C, Canez CR, Le Boeuf F, ... Bell JC, et al. First-in-class small molecule potentiators of cancer virotherapy. Scientific Reports. 6: 26786. PMID 27226390 DOI: 10.1038/srep26786  0.72
2016 Falls T, Roy DG, Bell JC, Bourgeois-Daigneault MC. Murine Tumor Models for Oncolytic Rhabdo-Virotherapy. Ilar Journal / National Research Council, Institute of Laboratory Animal Resources. 57: 73-85. PMID 27034397 DOI: 10.1093/ilar/ilv048  0.72
2016 Jiao Y, Zhou L, Ma F, Gao G, Kou L, Bell JM, Sanvito S, Du A. Predicting Single-Layer Technetium Dichalcogenides (TcX2, X=S, Se) with Promising Applications in Photovoltaics and Photocatalysis. Acs Applied Materials & Interfaces. PMID 26859697 DOI: 10.1021/acsami.5b12606  0.32
2015 Ard R, Mulatz K, Pomoransky JL, Parks RJ, Trinkle-Mulcahy L, Bell JC, Gee SH. Regulation of Macropinocytosis by Diacylglycerol Kinase ζ. Plos One. 10: e0144942. PMID 26701304 DOI: 10.1371/journal.pone.0144942  0.72
2015 Jiao Y, Ma F, Gao G, Bell J, Frauenheim T, Du A. Versatile Single-Layer Sodium Phosphidostannate(II): Strain-Tunable Electronic Structure, Excellent Mechanical Flexibility, and an Ideal Gap for Photovoltaics. The Journal of Physical Chemistry Letters. 6: 2682-7. PMID 26266848 DOI: 10.1021/acs.jpclett.5b01136  0.32
2015 Bell JC, McFadden G. Editorial overview: Oncolytic viruses--replicating virus therapeutics for the treatment of cancer. Current Opinion in Virology. 13: viii-ix. PMID 26260227 DOI: 10.1016/j.coviro.2015.07.005  0.72
2015 Breitbach CJ, Parato K, Burke J, Hwang TH, Bell JC, Kirn DH. Pexa-Vec double agent engineered vaccinia: oncolytic and active immunotherapeutic. Current Opinion in Virology. 13: 49-54. PMID 25900822 DOI: 10.1016/j.coviro.2015.03.016  0.72
2015 Arulanandam R, Batenchuk C, Varette O, Zakaria C, Garcia V, Forbes NE, Davis C, Krishnan R, Karmacharya R, Cox J, Sinha A, Babawy A, Waite K, Weinstein E, Falls T, ... ... Bell JC, et al. Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killing. Nature Communications. 6: 6410. PMID 25817275 DOI: 10.1038/ncomms7410  0.72
2015 Evgin L, Acuna SA, Tanese de Souza C, Marguerie M, Lemay CG, Ilkow CS, Findlay CS, Falls T, Parato KA, Hanwell D, Goldstein A, Lopez R, Lafrance S, Breitbach CJ, Kirn D, ... ... Bell JC, et al. Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaques. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 1066-76. PMID 25807289 DOI: 10.1038/mt.2015.49  0.72
2015 Bell JG, Wang J. Complex spatiotemporal behavior in the photosensitive ferroin-bromate-4-nitrophenol reaction. The Journal of Physical Chemistry. A. 119: 3323-8. PMID 25772194 DOI: 10.1021/acs.jpca.5b00402  0.32
2015 Cripe TP, Ngo MC, Geller JI, Louis CU, Currier MA, Racadio JM, Towbin AJ, Rooney CM, Pelusio A, Moon A, Hwang TH, Burke JM, Bell JC, Kirn DH, Breitbach CJ. Phase 1 study of intratumoral Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus, in pediatric cancer patients. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 602-8. PMID 25531693 DOI: 10.1038/mt.2014.243  0.72
2015 Zeh HJ, Downs-Canner S, McCart JA, Guo ZS, Rao UN, Ramalingam L, Thorne SH, Jones HL, Kalinski P, Wieckowski E, O'Malley ME, Daneshmand M, Hu K, Bell JC, Hwang TH, et al. First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activity. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 202-14. PMID 25292189 DOI: 10.1038/mt.2014.194  0.72
2014 Yuan W, Xia Y, Bell CG, Yet I, Ferreira T, Ward KJ, Gao F, Loomis AK, Hyde CL, Wu H, Lu H, Liu Y, Small KS, Viñuela A, Morris AP, ... ... Bell JT, et al. An integrated epigenomic analysis for type 2 diabetes susceptibility loci in monozygotic twins. Nature Communications. 5: 5719. PMID 25502755 DOI: 10.1038/ncomms6719  0.32
2014 Lichty BD, Breitbach CJ, Stojdl DF, Bell JC. Going viral with cancer immunotherapy. Nature Reviews. Cancer. 14: 559-67. PMID 24990523 DOI: 10.1038/nrc3770  0.72
2014 Bell J. Oncolytic viruses: immune or cytolytic therapy? Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1231-2. PMID 24981435 DOI: 10.1038/mt.2014.94  0.72
2014 Muharemagic D, Zamay A, Ghobadloo SM, Evgin L, Savitskaya A, Bell JC, Berezovski MV. Aptamer-facilitated Protection of Oncolytic Virus from Neutralizing Antibodies. Molecular Therapy. Nucleic Acids. 3: e167. PMID 24892725 DOI: 10.1038/mtna.2014.19  0.72
2014 Bell JC. Taming measles virus to create an effective cancer therapeutic. Mayo Clinic Proceedings. 89: 863-5. PMID 24835529 DOI: 10.1016/j.mayocp.2014.04.009  0.72
2014 Muik A, Stubbert LJ, Jahedi RZ, Geiβ Y, Kimpel J, Dold C, Tober R, Volk A, Klein S, Dietrich U, Yadollahi B, Falls T, Miletic H, Stojdl D, Bell JC, et al. Re-engineering vesicular stomatitis virus to abrogate neurotoxicity, circumvent humoral immunity, and enhance oncolytic potency. Cancer Research. 74: 3567-78. PMID 24812275 DOI: 10.1158/0008-5472.CAN-13-3306  0.72
2014 Zhang J, Tai LH, Ilkow CS, Alkayyal AA, Ananth AA, de Souza CT, Wang J, Sahi S, Ly L, Lefebvre C, Falls TJ, Stephenson KB, Mahmoud AB, Makrigiannis AP, Lichty BD, ... Bell JC, et al. Maraba MG1 virus enhances natural killer cell function via conventional dendritic cells to reduce postoperative metastatic disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1320-32. PMID 24695102 DOI: 10.1038/mt.2014.60  0.72
2014 Abdelbary H, Brown CW, Werier J, Bell J. Using targeted virotherapy to treat a resistant Ewing sarcoma model: from the bedside to the bench and back. Thescientificworldjournal. 2014: 171439. PMID 24672293 DOI: 10.1155/2014/171439  0.72
2014 Bell J, McFadden G. Viruses for tumor therapy. Cell Host & Microbe. 15: 260-5. PMID 24629333 DOI: 10.1016/j.chom.2014.01.002  0.72
2014 Cronin M, Le Boeuf F, Murphy C, Roy DG, Falls T, Bell JC, Tangney M. Bacterial-mediated knockdown of tumor resistance to an oncolytic virus enhances therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1188-97. PMID 24569832 DOI: 10.1038/mt.2014.23  0.72
2014 Beug ST, Tang VA, LaCasse EC, Cheung HH, Beauregard CE, Brun J, Nuyens JP, Earl N, St-Jean M, Holbrook J, Dastidar H, Mahoney DJ, Ilkow C, Le Boeuf F, Bell JC, et al. Smac mimetics and innate immune stimuli synergize to promote tumor death. Nature Biotechnology. 32: 182-90. PMID 24463573 DOI: 10.1038/nbt.2806  0.72
2014 Wang H, Xu X, Fassett J, Kwak D, Liu X, Hu X, Falls TJ, Bell JC, Li H, Bitterman P, Bache RJ, Chen Y. Double-stranded RNA-dependent protein kinase deficiency protects the heart from systolic overload-induced congestive heart failure. Circulation. 129: 1397-406. PMID 24463368 DOI: 10.1161/CIRCULATIONAHA.113.002209  0.72
2014 Ilkow CS, Swift SL, Bell JC, Diallo JS. From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer. Plos Pathogens. 10: e1003836. PMID 24453963 DOI: 10.1371/journal.ppat.1003836  0.72
2014 Liu YP, Wang J, Avanzato VA, Bakkum-Gamez JN, Russell SJ, Bell JC, Peng KW. Oncolytic vaccinia virotherapy for endometrial cancer. Gynecologic Oncology. 132: 722-9. PMID 24434058 DOI: 10.1016/j.ygyno.2014.01.009  0.72
2014 Ottolino-Perry K, Tang N, Head R, Ng C, Arulanandam R, Angarita FA, Acuna SA, Chen Y, Bell J, Dacosta RS, McCart JA. Tumor vascularization is critical for oncolytic vaccinia virus treatment of peritoneal carcinomatosis. International Journal of Cancer. Journal International Du Cancer. 134: 717-30. PMID 23893655 DOI: 10.1002/ijc.28395  0.72
2013 Pol JG, Marguerie M, Arulanandam R, Bell JC, Lichty BD. Panorama from the oncolytic virotherapy summit. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1814-8. PMID 24081122 DOI: 10.1038/mt.2013.207  0.72
2013 Forbes NE, Abdelbary H, Lupien M, Bell JC, Diallo JS. Exploiting tumor epigenetics to improve oncolytic virotherapy. Frontiers in Genetics. 4: 184. PMID 24062768 DOI: 10.3389/fgene.2013.00184  0.72
2013 Tai LH, Zhang J, Scott KJ, de Souza CT, Alkayyal AA, Ananth AA, Sahi S, Adair RA, Mahmoud AB, Sad S, Bell JC, Makrigiannis AP, Melcher AA, Auer RC. Perioperative influenza vaccination reduces postoperative metastatic disease by reversing surgery-induced dysfunction in natural killer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 5104-15. PMID 23881927 DOI: 10.1158/1078-0432.CCR-13-0246  0.72
2013 Le BÅ“uf F, Batenchuk C, Vähä-Koskela M, Breton S, Roy D, Lemay C, Cox J, Abdelbary H, Falls T, Waghray G, Atkins H, Stojdl D, Diallo JS, Kærn M, Bell JC. Model-based rational design of an oncolytic virus with improved therapeutic potential. Nature Communications. 4: 1974. PMID 23764612 DOI: 10.1038/ncomms2974  0.72
2013 Conrad DP, Tsang J, Maclean M, Diallo JS, Le Boeuf F, Lemay CG, Falls TJ, Parato KA, Bell JC, Atkins HL. Leukemia cell-rhabdovirus vaccine: personalized immunotherapy for acute lymphoblastic leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 3832-43. PMID 23714728 DOI: 10.1158/1078-0432.CCR-12-3199  0.72
2013 Kim MK, Breitbach CJ, Moon A, Heo J, Lee YK, Cho M, Lee JW, Kim SG, Kang DH, Bell JC, Park BH, Kirn DH, Hwang TH. Oncolytic and immunotherapeutic vaccinia induces antibody-mediated complement-dependent cancer cell lysis in humans Science Translational Medicine. 5. PMID 23677592 DOI: 10.1126/scitranslmed.3005361  0.72
2013 Yang D, Zhao J, Liu H, Zheng Z, Adebajo MO, Wang H, Liu X, Zhang H, Zhao JC, Bell J, Zhu H. Enhancing photoactivity of TiO2(B)/anatase core-shell nanofibers by selectively doping cerium ions into the TiO2(B) core. Chemistry (Weinheim An Der Bergstrasse, Germany). 19: 5113-9. PMID 23417892 DOI: 10.1002/chem.201202719  0.72
2013 Heo J, Reid T, Ruo L, Breitbach CJ, Rose S, Bloomston M, Cho M, Lim HY, Chung HC, Kim CW, Burke J, Lencioni R, Hickman T, Moon A, Lee YS, ... ... Bell JC, et al. Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer. Nature Medicine. 19: 329-36. PMID 23396206 DOI: 10.1038/nm.3089  0.72
2013 Breitbach CJ, Arulanandam R, De Silva N, Thorne SH, Patt R, Daneshmand M, Moon A, Ilkow C, Burke J, Hwang TH, Heo J, Cho M, Chen H, Angarita FA, Addison C, ... ... Bell JC, et al. Oncolytic vaccinia virus disrupts tumor-associated vasculature in humans. Cancer Research. 73: 1265-75. PMID 23393196 DOI: 10.1158/0008-5472.CAN-12-2687  0.72
2013 Moussavi M, Tearle H, Fazli L, Bell JC, Jia W, Rennie PS. Targeting and killing of metastatic cells in the transgenic adenocarcinoma of mouse prostate model with vesicular stomatitis virus Molecular Therapy. 21: 842-848. PMID 23337981 DOI: 10.1038/mt.2012.285  0.72
2013 Bridle BW, Chen L, Lemay CG, Diallo JS, Pol J, Nguyen A, Capretta A, He R, Bramson JL, Bell JC, Lichty BD, Wan Y. HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapy Molecular Therapy. 21: 887-894. PMID 23295947 DOI: 10.1038/mt.2012.265  0.72
2013 Vähä-Koskela MJ, Le Boeuf F, Lemay C, De Silva N, Diallo JS, Cox J, Becker M, Choi Y, Ananth A, Sellers C, Breton S, Roy D, Falls T, Brun J, Hemminki A, ... ... Bell JC, et al. Resistance to two heterologous neurotropic oncolytic viruses, Semliki Forest virus and vaccinia virus, in experimental glioma. Journal of Virology. 87: 2363-6. PMID 23221568 DOI: 10.1128/JVI.01609-12  0.72
2013 Seth R, Tai LH, Falls T, De Souza CT, Bell JC, Carrier M, Atkins H, Boushey R, Auer RA. Surgical stress promotes the development of cancer metastases by a coagulation-dependent mechanism involving natural killer cells in a murine model Annals of Surgery. 258: 158-168. PMID 23108132 DOI: 10.1097/SLA.0b013e31826fcbdb  0.72
2013 Tai LH, De Souza CT, Bélanger S, Ly L, Alkayyal AA, Zhang J, Rintoul JL, Ananth AA, Lam T, Breitbach CJ, Falls TJ, Kirn DH, Bell JC, Makrigiannis AP, Auer RA. Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells Cancer Research. 73: 97-107. PMID 23090117 DOI: 10.1158/0008-5472.CAN-12-1993  0.72
2012 Azizi A, Mironov GG, Muharemagic D, Wehbe M, Bell JC, Berezovski MV. Viral quantitative capillary electrophoresis for counting and quality control of RNA viruses Analytical Chemistry. 84: 9585-9591. PMID 23046075 DOI: 10.1021/ac302525y  0.72
2012 Muharemagic D, Labib M, Ghobadloo SM, Zamay AS, Bell JC, Berezovski MV. Anti-Fab aptamers for shielding virus from neutralizing antibodies Journal of the American Chemical Society. 134: 17168-17177. PMID 23016897 DOI: 10.1021/ja306856y  0.72
2012 Furió V, Garijo R, Durán M, Moya A, Bell JC, Sanjuán R. Relationship between within-host fitness and virulence in the vesicular stomatitis virus: correlation with partial decoupling. Journal of Virology. 86: 12228-36. PMID 22951843 DOI: 10.1128/JVI.00755-12  0.72
2012 Russell SJ, Peng KW, Bell JC. Oncolytic virotherapy Nature Biotechnology. 30: 658-670. PMID 22781695 DOI: 10.1038/nbt.2287  0.72
2012 Lemay CG, Rintoul JL, Kus A, Paterson JM, Garcia V, Falls TJ, Ferreira L, Bridle BW, Conrad DP, Tang VA, Diallo JS, Arulanandam R, Le Boeuf F, Garson K, Vanderhyden BC, ... ... Bell JC, et al. Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccine. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 1791-9. PMID 22760544 DOI: 10.1038/mt.2012.128  0.72
2012 Bell JC. The virus that came in from the cold Science Translational Medicine. 4. PMID 22700951 DOI: 10.1126/scitranslmed.3004139  0.72
2011 Magico AC, Bell JB. Identification of a classical bipartite nuclear localization signal in the Drosophila TEA/ATTS protein scalloped. Plos One. 6: e21431. PMID 21731746 DOI: 10.1371/journal.pone.0021431  1
2010 Deng H, Bell JB, Simmonds AJ. Vestigial is required during late-stage muscle differentiation in Drosophila melanogaster embryos. Molecular Biology of the Cell. 21: 3304-16. PMID 20685961 DOI: 10.1091/mbc.E10-04-0364  1
2009 Deng H, Hughes SC, Bell JB, Simmonds AJ. Alternative requirements for Vestigial, Scalloped, and Dmef2 during muscle differentiation in Drosophila melanogaster. Molecular Biology of the Cell. 20: 256-69. PMID 18987343 DOI: 10.1091/mbc.E08-03-0288  1
2007 Garg A, Srivastava A, Davis MM, O'Keefe SL, Chow L, Bell JB. Antagonizing scalloped with a novel vestigial construct reveals an important role for scalloped in Drosophila melanogaster leg, eye and optic lobe development. Genetics. 175: 659-69. PMID 17110491 DOI: 10.1534/genetics.106.063966  0.96
2004 Srivastava A, Simmonds AJ, Garg A, Fossheim L, Campbell SD, Bell JB. Molecular and functional analysis of scalloped recessive lethal alleles in Drosophila melanogaster. Genetics. 166: 1833-43. PMID 15126402 DOI: 10.1534/genetics.166.4.1833  1
2003 Srivastava A, Bell JB. Further developmental roles of the Vestigial/Scalloped transcription complex during wing development in Drosophila melanogaster. Mechanisms of Development. 120: 587-96. PMID 12782275  0.96
2003 MacKay JO, Soanes KH, Srivastava A, Simmonds A, Brook WJ, Bell JB. An in vivo analysis of the vestigial gene in Drosophila melanogaster defines the domains required for Vg function. Genetics. 163: 1365-73. PMID 12702681  1
2002 Srivastava A, Heise C, Garg A, Bell JB. The relationship between the dominant Additional vein mutant in Drosophila melanogaster and engrailed. Genome / National Research Council Canada = GéNome / Conseil National De Recherches Canada. 45: 1077-82. PMID 12502252  0.96
2002 Srivastava A, MacKay JO, Bell JB. A Vestigial:Scalloped TEA domain chimera rescues the wing phenotype of a scalloped mutation in Drosophila melanogaster. Genesis (New York, N.Y. : 2000). 33: 40-7. PMID 12001068 DOI: 10.1002/gene.10086  0.96
1998 Simmonds AJ, Liu X, Soanes KH, Krause HM, Irvine KD, Bell JB. Molecular interactions between Vestigial and Scalloped promote wing formation in Drosophila. Genes & Development. 12: 3815-20. PMID 9869635  1
1998 Simmonds AJ, Bell JB. A genetic and molecular analysis of an invectedDominant mutation in Drosophila melanogaster. Genome / National Research Council Canada = GéNome / Conseil National De Recherches Canada. 41: 381-90. PMID 9729772  1
1997 Simmonds A, Hughes S, Tse J, Cocquyt S, Bell J. The effect of dominant vestigial alleles upon vestigial-mediated wing patterning during development of Drosophila melanogaster. Mechanisms of Development. 67: 17-33. PMID 9347912 DOI: 10.1016/S0925-4773(97)00096-8  1
1995 Simmonds AJ, Brook WJ, Cohen SM, Bell JB. Distinguishable functions for engrailed and invected in anterior-posterior patterning in the Drosophila wing. Nature. 376: 424-7. PMID 7630417 DOI: 10.1038/376424a0  1
1973 Bell J, MacIntyre R. Characterization of acid phosphatase-1 null activity mutants of Drosophila melanogaster. Biochemical Genetics. 10: 39-55. PMID 4201109 DOI: 10.1007/BF00485747  1
1972 Bell JB, MacIntyre RJ, Olivieri AP. Induction of null-activity mutants for the acid phosphatase-1 gene in Drosophila melanogaster. Biochemical Genetics. 6: 205-16. PMID 4199799 DOI: 10.1007/BF00486404  1
Show low-probability matches.